Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families.
By A. Alkhateeb, P. Fain, A. Thody, D. Bennett, R. Spritz. Pigment Cell Research, 2003
709 citations recorded by the source corpus.
Subfields: Cell Biology, Immunology, Nutrition and Dietetics
View Paper: https://www.semanticscholar.org/paper/ce035cfedd1dc22aeab891c9d5d8c9334f5467f2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- E. Somers
- G. Cooper
- M. Bynum
Citations in the corpus
- Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. (2011, neutral): “Among vitiligo patients, 20% report thyroid disease (an 8-fold increase over the general population), particularly hypothyroidism.(18) Similarly, there is an increased frequency in other forms of autoimmune disease and autoimmune polyendocrine syndromes (Table III).”
- Recent Insights in the Epidemiology of Autoimmune Diseases: Improved Prevalence Estimates and Understanding of Clustering of Diseases (2009, background): “1.3)c Pernicious anemia 123 (2.4); 25 (0.9) 2.7 (1.7, 4.3)c SLE 28 (0.6); 7 (0.3) 2.2 (0.9, 5.9)c Vitiligo 35 (0.7); 12 (0.4) 1.6 (0.8, 3.3)c AITD 395 (7.9); 116 (4.3) 1.9 (1.5, 2.4)c MG 7 (0.1); 3 (0.1) 1.3 (0.3, 7.5)c ≥1 of above Not reported 1.1 (95% CI 0.86–1.2)c Weng[151] California, US Kaiser ”